<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Intractable Rare Dis Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Intractable Rare Dis Res</journal-id>
<journal-id journal-id-type="publisher-id">irdr</journal-id>
<journal-id journal-id-type="hwp">irdr</journal-id>
<journal-title-group>
<journal-title>Intractable &amp; Rare Diseases Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">2186-3644</issn>
<issn pub-type="epub">2186-361X</issn>
<publisher>
<publisher-name>International Research and Cooperation Association for Bio &amp; Socio-Sciences Advancement</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32494560</article-id>
<article-id pub-id-type="pmc">7263992</article-id>
<article-id pub-id-type="doi">10.5582/irdr.2020.01028</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title> Fragile X associated neuropsychiatric disorders in a male without FXTAS </article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cabal-Herrera</surname>
<given-names>Ana María</given-names>
</name>
<xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="a2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saldarriaga-Gil</surname>
<given-names>Wilmar</given-names>
</name>
<xref ref-type="aff" rid="a2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salcedo-Arellano</surname>
<given-names>Maria Jimena</given-names>
</name>
<xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="a3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagerman</surname>
<given-names>Randi J</given-names>
</name>
<xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="a3">
<sup>3</sup>
</xref>
</contrib>
<aff id="a1">
<label>1</label> Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis Health, Sacramento, CA, USA;</aff>
<aff id="a2">
<label>2</label> School of Medicine, Universidad del Valle, Cali, Colombia;</aff>
<aff id="a3">
<label>3</label> Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA, USA.</aff>
</contrib-group>
<author-notes>
<corresp id="c1"><label>*</label><italic>Address correspondence to:</italic>Ana María Cabal-Herrera, School of Medicine, Universidad del Valle, Cali, Colombia. E-mail: <email>ana.cabal@correounivalle.edu.co</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>5</month>
<year>2020</year>
</pub-date>
<volume>9</volume>
<issue>2</issue>
<fpage>113</fpage>
<lpage>118</lpage>
<history>
<date date-type="received">
<day>6</day>
<month>3</month>
<year>2020</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>5</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>2020, International Research and Cooperation Association for Bio &amp; Socio - Sciences Advancement</copyright-statement>
<copyright-year>2020</copyright-year>
</permissions>
<abstract>
<title>Summary</title>
<p>Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and autism spectrum disorder. In most cases, it is due to an expansion of the CGG triplet to more than 200 repeats within the promoter region of the <italic>FMR1</italic> gene. In the premutation (PM) the trinucleotide is expanded to 55-200 repeats. PM carriers can present with disorders associated with the PM including fragile X-associated tremor/ataxia syndrome (FXTAS) and fragile X-associated ovarian insufficiency (FXPOI). Recently fragile X-associated neuropsychiatric disorders (FXAND) was proposed as an umbrella term to include the neuropsychiatric disorders that are more prevalent in PM carriers compared to the general population such as anxiety, depression, chronic fatigue, alcohol abuse, and psychosis, among others. The patient in our study was evaluated by a team of clinicians from the University del Valle in Cali who traveled to Ricaurte, a Colombian town known for being a genetic geographic cluster of FXS. A detailed medical history was collected and complete physical, neurological and psychiatric evaluations were performed in addition to molecular and neuroradiological studies. We report the case of a 78-year-old man, PM carrier, without FXTAS whose main clinical presentation consists of behavioral changes and psychosis. Brain imaging revealed white matter lesions in the periventricular region and mild cerebral atrophy. Although anxiety and depression are the most common neuropsychiatric manifestations in PM carriers, it is important to perform a complete psychiatric evaluation since some patients may present with behavioral changes and psychosis.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>fragile X mental retardation 1 gene</kwd>
<kwd>fragile X-associated neuropsychiatric disorders</kwd>
<kwd>premutation</kwd>
<kwd>FXAND</kwd>
<kwd>psychosis</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<ref-count count="43"></ref-count>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>